FDA Approves New Weapon in Widening War on Prostate Cancer
Dr. Crawford is discusses the FDA approval of Xtandi as a New Weapon in Widening the War on Prostate Cancer. Click here to learn more
PROFESSOR OF SURGERY, UROLOGY AND RADIATION ONCOLOGY
HEAD, UROLOGIC ONCOLOGY
UNIVERSITY OF COLORADO
ANSCHUTZ MEDICAL CAMPUS
E. David Crawford, MD
